TECHINNOVATION TECH OFFERS

Enterprises today face mounting challenges from legacy systems, fragmented data silos, and complex integration issues that slow down digital and AI initiatives. This AI-powered automation platform transforms integration from a technical bottleneck into a strategic accelerator, enabling organizations to unlock trapped data assets worth billions. By automating up to 70% of manual coding, the platform accelerates processing speeds by up to 10x while reducing operational costs. Its visual drag-and-drop interface democratizes data access, addressing the $5.5 trillion global skills gap by removing the need for specialized coding expertise. Enterprises can cut data preparation efforts from 80% to 20% of project cycles, connecting legacy mainframes seamlessly with modern cloud applications. The urgency is clear: the data integration market is projected to reach $47.6 billion by 2034, yet 95% of IT leaders cite integration as the main barrier to AI adoption. Meanwhile, silos cost enterprises hundreds of thousands annually, and up to 80% of data projects fail due to poor preparation. This platform empowers organizations to process millions of records in minutes across hybrid, cloud, and on-premises environments. Early adopters already report 171–295% ROI within three years, six-month payback periods, and over $2.4 million in productivity gains. With 70% of new applications expected to leverage low-code/no-code by 2026, this solution positions enterprises to lead the next wave of intelligent automation.

This innovative technology addresses the critical challenge of complex medical information interpretation that patients face daily. The solution transforms healthcare delivery through artificial intelligence by providing hyper-personalized, patient-friendly care that makes medical data accessible and meaningful to patients. The platform empowers patients with AI agents that organize and decode complex medical information, delivering instant personalized answers through enterprise-grade medical chatbots and tailored tools with expert insights. The technology bridges the gap between complex medical terminology and patient comprehension, significantly reducing the time required to interpret and understand medical information. With over 600,000 patient-uploaded medical documents and 120,000 registered patients (70%+ cancer patients) and caregivers, the platform has demonstrated substantial market adoption. This solution provides comprehensive end-to-end healthcare support, seamlessly connecting the entire patient journey from screening to follow-up care through integrated data synchronization and HIPAA-compliant infrastructure. The technology owner is seeking collaborations with: Hospital systems (EMR, HER vendors) for integrated deployment. Telemedicine platforms requiring AI-powered patient support. Pharmaceutical companies developing digital therapeutics. Medical device manufacturers seeking patient education integration. Healthcare insurance providers implementing value-based care programs. Healthcare technology accelerators and innovation hub.

When companies engage in large-scale physical operations, various work processes and system are required to scale up to ensure the smooth operation while maintaining its expected performance. However, due to various systems (e.g., CCTV, IoT sensors, BIM models, manual checklists) being in respective disconnected data silos, this leads to reactive decision-making, operational inefficiencies, and compliance gaps, which is definitely less than ideal. The technology solution addresses this critical pain point by providing an AI digital platform unifying fragmented data into a single, actionable source of operational intelligence, eliminating reliance on error-prone paper-based processes and disjointed tools. This platform leverages on a digital twin infrastructure to consolidate all data silos into a single point of truth for various business unit’s operation, maintaining operational efficiencies and compliance. By leveraging on their Generative AI (Gen-AI) module to generate predictive insights, it enables proactive management (e.g., pre-empting safety hazards, forecasting maintenance needs) instead of post-incident responses, directly addressing the market need for cost-effective, scalable operational excellence. The technology owner is currently seeking industrial collaborators with complex physical assets (e.g. construction, manufacturing, FM, smart cities and healthcare) looking to streamline operational workflow, enhance safety and optimise resource utilisation.

This technology presents a regenerative medicine approach for treating fingertip loss by using nail stem cells derived from human induced pluripotent stem (iPS) cells. The loss of fingertip can arise from burns, trauma accidents, crush injuries due to heavey machineries and tools. Fingertip amputations are currently managed with conservative treatments that often result in shortening and deformation, with limited options for restoring full form and function. By leveraging the regenerative potential of nail stem cells, this therapy aims to achieve structural and functional regeneration of the fingertip, including nail reconstruction. A patent has been filed for the method of generating nail tissues and nail stem cells from human iPS cells, supporting future clinical translation and application. Ideal Collaboration Partner: Pharmaceutical and biotechnology companies with an interest in advancing cell-based regenerative medicine therapies, particularly those with expertise in clinical development and commercialization.

In Singapore, where workplace safety is of paramount concern, the Ministry of Manpower (MOM) have always been actively monitoring with compliance and enforcement to meet their objective of less than one workplace fatality per 100,000 workers by 2028. Unfortunately, workplace deaths have been steadily increasing, with falling from height being the highest cause of incident within the construction industry in 2024 with inadequate Workplace Safety and Health (WSH) management, non-compliance and unsafe behaviour being common root causes. With potential loss of man-day and even life, companies are actively looking for solutions which ensure workers working-at-height are safe and compliant. The technology owner has developed an innovative safety solution designed to enhance safety for workers operating at heights. It provides relevant stakeholders with real-time information about the usage of safety harnesses, as well as the precise or general positioning of the worker before, during and after work-at-height (WAH) activities. This capability enables effective monitoring of compliance of workers in high-risk areas and facilitates the implementation of follow-up training and safety improvements. The technology solution has been successfully tested and deployed in various construction sites in Hong Kong. The owner is currently looking for industrial players, such as contractors, and facility management teams, who will find this solution valuable for reinforcing compliance and reducing WAH risk across various operations.

Encapsulation of live cells involves enclosing them within a semi-permeable barrier that protects against immune attack and mechanical stress while allowing the exchange of nutrients and signaling molecules. This approach is widely used in biomedical research, diagnostics, and cell therapy manufacturing. Conventional methods typically suspend cells in polymer solutions that are cross-linked into beads or gels, sometimes preceded by microwell aggregation. While established, these approaches often suffer from limited adaptability, inconsistent sample sizes, and labor-intensive retrieval processes. This technology introduces an adaptive elastomeric microwell platform that enables adjustable dimensions and high-throughput encapsulation of biological samples. It can accommodate a wide range of sample sizes, from single cells to complex multicellular aggregates such as tumor spheroids and organoids. The platform supports physiologically relevant growth and proliferation, and importantly, allows encapsulated samples to be released intact without enzymatic or harsh mechanical disruption. By combining flexibility, secure encapsulation, and gentle retrieval, this solution addresses a clear market need for customizable and cost-efficient live cell handling. It holds strong potential for research institutions and Institutes of Higher Learning engaged in cell biology, organoid research, and advanced drug screening; for pharmaceutical and biotechnology companies seeking scalable, contamination-free sample preparation for R&D and clinical use; and for clinical laboratories and hospitals requiring standardized, zero-loss handling of rare or patient-derived samples. In addition, laboratory equipment and consumables manufacturers may benefit from integrating this platform into existing product lines or automation systems, extending its impact across the broader life sciences and healthcare ecosystem.

The technology is an AI-enabled, media-driven, and community-integrated digital health platform designed to empower seniors to live healthier, more engaged, and more independent lives. For seniors:  accessible, engaging, and personalised health and wellness guidance, inclusive of those who are wheelchair-bound. For families & caregivers: real-time progress monitoring and encouragement tools. For community organisations: scalable and customisable platform to run wellness programmes. For healthcare & policy stakeholders: data-driven insights into preventive health, functional decline, and community engagement impact. The platform is supported by industry and academic partners and has received encouraging initial feedback from community and hospital proof-of-concept trials. The technology owner seeks licensing opportunities with community care organisations or tech companies, partnerships with healthcare providers, government agencies, and insurers, as well as scaling partners for secure cloud deployment of AI models and applications. They are also looking for collaborators to co-develop new media IPs and gamified challenges for regional markets.

Insurers are increasingly shifting from traditional static underwriting to data-driven models that leverage health data and medical records. With advances in digital health infrastructure and wider availability of electronic medical records, insurers can now assess risk more accurately and personalize premiums.  Beyond pricing, insurers are also using health data to incentivize preventive behaviors, rewarding policyholders who maintain healthier lifestyles with reduced premiums or benefits. This convergence of healthcare and insurance reflects a broader move towards proactive, personalized, and engagement-driven insurance models. This technology known as HealthGrade quantifies individuals health status based on digital health data such as health check-ups and medical usage history. By using it like a credit score in the credit market, HealthGrade aims to innovate insurance pricing and underwriting. It personalizes underwriting decisions beyond static rule-based methods. HealthGrade is currently used by insurers and helps develop health-promoting products offering financial rewards for healthier behaviors. This creates mutual value for insurers and consumers. The technology owner is seeking to partner with:  Insurance and Reinsurance companies Healthcare companies looking to leverage big data Government association for public health Regulatory sandbox entities in Asia 

With rising global temperatures, the demand for energy-efficient cooling solutions is becoming increasingly urgent, particularly in tropical regions. Conventional cooling solutions such as air-conditioning and mechanical ventilation not only consume large amounts of electricity also emit greenhouse gases, further accelerating climate change. Solar reflective paints offer a sustainable solution by reducing heat absorption in buildings, thereby lowering indoor temperatures, cutting energy costs, and decreasing carbon footprint. However, their performance declines over time due to dirt accumulation, which reduces effectiveness and shortens the coating’s lifespan. To address this challenge, the technology owner has developed a novel functional additive that significantly improves the dirt pick-up resistance (DPUR) of solar reflective paints. By post-production incorporation into the painting, the additive enhances overall effectiveness and longevity while maintaining essential painting properties such as consistency and opacity. This solution extending painting’s solar reflectance by up to 6 times longer than traditional paintings, significantly reducing building cooling loads and lowering maintenance. The technology owner is actively seeking collaborations with relevant industrial partners to explore IP licensing opportunities.